Irinotecan in Treating Patients With Colorectal Cancer

Part of paid clinical trials in Duarte, California.

Sponsor
California Cancer Consortium
Study ID
NCT00003843
Status
Terminated

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating patients who have colorectal cancer.

Key Dates

Start date
Oct 31, 1998
Status verified
Sep 2013
Primary completion
Feb 28, 2001
Completion
Feb 28, 2001

Study Design

Enrollment
28 participants (estimated)

Locations (3)

FacilityCityStateZIPSite coordinators
City of Hope Comprehensive Cancer CenterDuarteCalifornia91010-
USC/Norris Comprehensive Cancer Center and HospitalLos AngelesCalifornia90033-0804-
University of California Davis Cancer CenterSacramentoCalifornia95817-

Find similar trials in Duarte, CA

By condition
Colorectal cancer
By specialty
OncologyGI oncology
By research site
City of Hope Comprehensive Cancer Center· Duarte, CAUSC/Norris Comprehensive Cancer Center and Hospital· Los Angeles, CAUniversity of California Davis Cancer Center· Sacramento, CA

Related Studies